2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual

Partnering Events:

TechConnect Summit
Clean Technology 2008

Nemucore Medical Innovations

T. Coleman
Nemucore Medical Innovations, US

pharmaceuticals, biotech

Nemucore Medical Innovations utilizes proprietary nanoformulation technology to develop generational improvements to widely used drugs and facilitate delivery of poorly soluble drugs. Nemucore is dedicated to the improvement of human therapy. Our mission is to innovate, develop, produce and sell efficacious nano-biopharmaceuticals within indications where our products can be considered a primary therapeutic alternative. Nemucore was founded by a team of highly experienced, successful serial entrepreneurs in the pharmaceutical and biotechnology industries and brings the highest level of scientific expertise in nanomedicine, drug development, and oncology. Our in vitro and in vivo data indicate that generic drugs can be delivered with improved clinical characteristics. Spontaneous Self Assembling Nanoparticles (SSANs) have utility across many indications. By developing this technology, we believe we can move an oncology compound to clinical trials during the next 24 months. In addition, we are proceeding with a two-pronged approach to provide a balanced and robust business platform; creating significant shareholder value. In addition to reformulation of existing oncology drugs (generics) we plan to partner in other indications such as poorly soluble drugs and drugs close to patent expiration.

Nanotech 2008 Conference Program Abstract